Three-year outcomes of the RESILIENT trial: are they enough to support a primary stenting policy?

Mark G Davies1

  • 1Department of Cardiovascular Surgery, Methodist DeBakey Heart & Vascular Center, The Methodist Hospital, Houston, Texas 77030, USA. MDavies@tmhs.org

Abstract

No abstract available in PubMed .